Skip to content
Screener

CG Oncology CGON Free cash flow margin

Free cash flow margin at other companies

Pfizer logo
PfizerPFE
18%+8.8pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
22.7%+2.2pp
Gilead Sciences logo
Gilead SciencesGILD
42.5%+10.0pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-212%-95.8pp
UroGen Pharma logo
UroGen PharmaURGN
-84.3%-22.2pp
Immunome logo
ImmunomeIMNM
-5,118.9%-8,601pp

Other financials

Income statement

See full
Revenue$1.2M
Operating income-$86.4M-77.3%
Net income-$79.1M-90.8%
EPS (diluted)-$0.90-66.7%

Balance sheet

See full
Cash & equivalents$19.6M+34.3%
Total debt$8.8M+787%
Total equity$1.0B+53.5%
Total assets$1.1B+54.8%

Cash flow

See full
Operating cash flow-$46.4M-66.0%
CapEx$468.0K+3,243%
Free cash flow-$46.9M-67.6%

Valuation

See full
Market cap$6.6B+242%
Enterprise value$6.59B+244%
P/S1,060×-2,439×

Profitability

See full
Operating margin-4,056.2%-1,873pp
Net margin-3,602.7%-1,650pp

Returns & leverage

See full
Return on equity-26.4%+9.3pp
Debt / equity0.0×
Current ratio22.2×+0.1×

Where this comes from

Calculated from CG Oncology’s reported figures.

Based on trailing twelve months.

The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 8:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336918

FAQ

What is CG Oncology's free cash flow margin?
CG Oncology (CGON) reported free cash flow margin of -2,879.6% in Q2 2026.
How has CG Oncology's free cash flow margin changed year-over-year?
CG Oncology's free cash flow margin increased by 83.1% year-over-year, from -17,069.9% to -2,879.6%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Ask your AI about CG Oncology's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude